RBC Europe’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

RBC Europe’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,225	Closed	-$21.4K	–	1256
2020 Q4	$21.4K	Hold	1,225	–	–	﹤0.01%	699
2020 Q3	$14.3K	Buy	1,225 +1,000	+444%	+$13.3K	﹤0.01%	721
2020 Q2	$2.92K	Buy	+225	New	+$2.7K	﹤0.01%	922

RBC Europe's OXFD Position: Q1 2021 in Review

RBC Europe sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 1,225 shares — an estimated $21.4K sold.

RBC Europe first reported a position in OXFD in Q2 2020 and held it in 3 quarters. The position peaked at $21.4K in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

RBC Europe reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
RBC Europe sold 1,225 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $21.4K.
RBC Europe first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2020 and held it in 3 quarters.
RBC Europe's Oxford Immunotec Global PLC Ordinary Shares position peaked at $21.4K in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on RBC Europe's 13F filing for Q1 2021, filed 9 Nov 2023.